Tianfeng Securities released a research report on April 14 stating that it gave Haoyue Nursing (605009.SH) a purchase rating. The main reasons for the rating include: 1) the company released its 2023 report; 2) large Thai and cross-border customers are growing beautifully, and overseas brands are expanding through multiple channels; 3) production capacity in Hubei has been released one after another to establish business expansion, and 4) reduced costs, self-produced raw materials, and increased profitability. (Mainichi Keizai Shimbun)
天风证券4月14日发布研报称，给予豪悦护理（605009.SH）买入评级。评级理由主要包括：1）公司发布2023年报；2）泰国及跨境大客户增长靓丽，海外品牌多渠道铺开；3）湖北产能陆续释放，拟购入合肥花王工厂奠定业务扩张；4）成本下降、原材料自产，盈利能力提升。（每日经济新闻）
Tianfeng Securities released a research report on April 14 stating that it gave Haoyue Nursing (605009.SH) a purchase rating. The main reasons for the rating include: 1) the company released its 2023 report; 2) large Thai and cross-border customers are gr
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated